[P25-10] P25-10: Oncologic drugs (2)

[P25-10-7] Preclinical and clinical studies on establishment of invasive marker of dihydropyrimidine dehydrogenase activity and its usefulness in 5-fluorouracil-based chemotherapy

Yukako Ito¹, Shinji Kobuchi², Shigeru Horiguchi³, Hironari Kato⁴, Hidenori Shiraha⁵, Toshiyuki Sakaeda⁶ (1.Kyoto Pharmaceutical University, 2.Kyoto Pharmaceutical University, 3.Okayama University Hospital, 4.Okayama University Hospital, 5.Okayama University Hospital, 6.Kyoto Pharmaceutical University)

キーワード：5-fluorouracil dihydropyrimidine dehydrogenase biomarker, FOLFIRINOX